General Information of the Compound
Compound ID
CP0134276
Compound Name
US10245267, Example 1156
    Show/Hide
Synonyms
1800398-38-2
BDBM88120
CS-0043317
HY-112089
LXH254
N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide
SCHEMBL16094629
UEPXBTCUIIGYCY-UHFFFAOYSA-N
US9694016, 1156
    Show/Hide
Structure
Formula
C25H25F3N4O4
Molecular Weight
502.493
Canonical SMILES
Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)N1CCOCC1
    Show/Hide
InChI
InChI=1S/C25H25F3N4O4/c1-16-2-3-19(30-24(34)17-4-5-29-21(12-17)25(26,27)28)15-20(16)18-13-22(32-6-9-35-10-7-32)31-23(14-18)36-11-8-33/h2-5,12-15,33H,6-11H2,1H3,(H,30,34)
    Show/Hide
InChIKey
UEPXBTCUIIGYCY-UHFFFAOYSA-N
CAS
1800398-38-2
Physicochemical Property
logP
3.93082
Rotatable Bonds
7
Heavy Atom Count
36
Polar Areas
96.81
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
7
Complexity
36

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 90456533
ChEMBL ID
CHEMBL4583691
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01116, RAF proto-oncogene serine/threonine-protein kinase
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000187 Calu-6 Homo sapiens (Human)  1
1
EC50 = 14 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.2 nM
2 IC50 = 8.6 nM
Protein ID: PT01381, Serine/threonine-protein kinase B-raf
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000045 A-375 Homo sapiens (Human)  1
1
IC50 = 78 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.4 nM
Clinical Information about the Compound
Drug 1 ( LXH254 )
Drug Name LXH254
Company Novartis Oncology East Hanover, NJ
Indication
Non-small-cell lung cancer
Phase 1
Target(s)
Raf messenger RNA (Raf mRNA)
Inhibitor